A detailed history of Eagle Bay Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 687 shares of DHR stock, worth $163,286. This represents 0.11% of its overall portfolio holdings.

Number of Shares
687
Previous 691 0.58%
Holding current value
$163,286
Previous $172,000 10.47%
% of portfolio
0.11%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$239.25 - $280.76 $957 - $1,123
-4 Reduced 0.58%
687 $190,000
Q2 2024

Jul 26, 2024

BUY
$235.51 - $267.98 $117,519 - $133,722
499 Added 259.9%
691 $172,000
Q1 2024

May 08, 2024

SELL
$224.58 - $256.19 $224 - $256
-1 Reduced 0.52%
192 $47,000
Q4 2023

Feb 08, 2024

SELL
$185.1 - $233.13 $89,033 - $112,135
-481 Reduced 71.36%
193 $44,000
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $10,255 - $11,685
44 Added 6.98%
674 $167,000
Q2 2023

Aug 10, 2023

SELL
$224.99 - $256.14 $6,974 - $7,940
-31 Reduced 4.69%
630 $151,000
Q1 2023

Apr 24, 2023

SELL
$239.75 - $277.0 $12,706 - $14,681
-53 Reduced 7.42%
661 $166,000
Q4 2022

Jan 26, 2023

BUY
$241.42 - $282.29 $49,491 - $57,869
205 Added 40.28%
714 $0
Q3 2022

Nov 22, 2022

SELL
$247.06 - $1507.4 $6,917 - $42,207
-28 Reduced 5.21%
509 $132,000
Q2 2022

Aug 19, 2022

BUY
$237.11 - $299.66 $127,328 - $160,917
537 New
537 $136 Million
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $118,858 - $145,881
-462 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$292.08 - $329.01 $27,163 - $30,597
-93 Reduced 16.76%
462 $152,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $2,177 - $2,659
-8 Reduced 1.42%
555 $168,000
Q2 2021

Jul 30, 2021

BUY
$225.08 - $271.69 $126,720 - $152,961
563 New
563 $155,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.